Your browser doesn't support javascript.
loading
Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli.
Davies, Timothy J; Stoesser, Nicole; Sheppard, Anna E; Abuoun, Manal; Fowler, Philip; Swann, Jeremy; Quan, T Phuong; Griffiths, David; Vaughan, Alison; Morgan, Marcus; Phan, Hang T T; Jeffery, Katie J; Andersson, Monique; Ellington, Matt J; Ekelund, Oskar; Woodford, Neil; Mathers, Amy J; Bonomo, Robert A; Crook, Derrick W; Peto, Tim E A; Anjum, Muna F; Walker, A Sarah.
Afiliación
  • Davies TJ; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom timothy.davies@ndm.ox.ac.uk.
  • Stoesser N; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Sheppard AE; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Abuoun M; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Fowler P; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Swann J; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Quan TP; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Griffiths D; Bacteriology, Animal and Plant Health Agency, Surrey, United Kingdom.
  • Vaughan A; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Morgan M; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Phan HTT; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Jeffery KJ; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Andersson M; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Ellington MJ; NIHR Biomedical Research Centre, Oxford, United Kingdom.
  • Ekelund O; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Woodford N; NIHR Biomedical Research Centre, Oxford, United Kingdom.
  • Mathers AJ; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Bonomo RA; NIHR Biomedical Research Centre, Oxford, United Kingdom.
  • Crook DW; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Peto TEA; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Anjum MF; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Walker AS; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Article en En | MEDLINE | ID: mdl-32205351

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Combinación Amoxicilina-Clavulanato de Potasio / Escherichia coli Tipo de estudio: Prognostic_studies / Qualitative_research País/Región como asunto: Europa Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Combinación Amoxicilina-Clavulanato de Potasio / Escherichia coli Tipo de estudio: Prognostic_studies / Qualitative_research País/Región como asunto: Europa Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido